Examkin

Soru

Zorluk: ZorCardiovascular System

A 6464-year-old man with a history of hypertension, hyperlipidemia, and a 4545-pack-year smoking history presents to the primary care clinic with a 33-month history of a cramping ache in his left calf. The pain reliably occurs after walking approximately two city blocks and resolves completely with 55 minutes of rest. He has no leg pain at rest and no history of foot ulcers. His blood pressure is 142/86142/86 mmHg, and his pulse is 7676/min. Physical examination reveals thinning of the skin and loss of hair on the distal lower extremities bilaterally. The dorsalis pedis and posterior tibial pulses are faintly palpable bilaterally.

Arrange the following management steps in the most appropriate chronological sequence for this patient, from the initial diagnostic step to the last-resort intervention.

  1. 1Obtain resting ankle-brachial index (ABI) measurements
  2. 2Implement a supervised graded exercise therapy program and prescribe cilostazol
  3. 3Perform non-invasive vascular imaging (e.g., computed tomography angiography)
  4. 4Perform surgical or endovascular limb revascularization

Cevap

The correct sequence for managing suspected peripheral arterial disease is to first confirm the diagnosis physiologically with resting ankle-brachial index (ABI) measurements. Once confirmed, initial treatment focuses on conservative measures, specifically a supervised exercise program and pharmacotherapy. If conservative therapy fails and symptoms remain lifestyle-limiting, the next step is anatomic mapping with non-invasive vascular imaging to plan for the final step, which is surgical or endovascular revascularization.
The correct sequential management of stable intermittent claudication begins with establishing the diagnosis via resting ankle-brachial index (ABI) measurement (an ABI ≤0.90\leq 0.90 is diagnostic). Once confirmed, the cornerstone of initial treatment is risk factor modification and a supervised graded exercise program, often supplemented with pharmacotherapy like cilostazol to increase pain-free walking distance. Advanced non-invasive vascular imaging (such as CTA or MRA) is deferred until conservative therapy proves inadequate and the patient's lifestyle-limiting symptoms warrant consideration for the final step: surgical or endovascular revascularization.

Adım Adım Çözüm

1
Identify the primary presentation as classical intermittent claudication without critical limb ischemia.
The patient has exertional calf pain relieved by rest, with no tissue loss or rest pain.
Differentiates stable PAD from critical limb ischemia, which would require an accelerated timeline for imaging and intervention.
2
Determine the initial diagnostic test.
Resting ankle-brachial index (ABI) measurement is selected.
ABI is the most cost-effective and sensitive first-line non-invasive test to definitively establish the diagnosis of PAD.
3
Select the appropriate initial therapy for stable claudication.
Supervised graded exercise therapy and cilostazol are implemented.
Conservative medical and exercise therapy is the evidence-based first-line treatment for claudication, successfully improving walking distance in the majority of patients.
4
Identify the indications for advanced imaging and subsequent revascularization.
Anatomic imaging (CTA) is deferred until conservative management fails, followed by definitive revascularization.
Imaging is only performed for pre-surgical mapping when conservative therapy is inadequate and intervention is actively warranted.

Anahtar Kavram

In patients with stable intermittent claudication due to peripheral arterial disease, initial diagnosis is made with Ankle-Brachial Index (ABI), followed immediately by conservative management (supervised exercise and medical therapy). Advanced imaging (e.g., CT angiography) is reserved solely for preoperative planning if conservative management fails and revascularization is required.
Tahmini Süre:1m 15s
Bu soruyu puanla

Konular

Cardiovascular System

Bu konudan daha fazla soru